Rovi

Pozuelo De Alarcon, Spain Founded: 1946 • Age: 80 yrs Listed
Pharmaceutical products manufacturer and CDMO services provider

About Rovi

Rovi is a publicly listed company based in Pozuelo De Alarcon (Spain) founded in 1946. Pharmaceutical products manufacturer and CDMO services provider. The company has 2,200 employees. Its chief executive, as recorded, is Juan Encina. Its website rovi.es draws about 17 thousand monthly visits. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.

Company details

Rovi was founded in 1946 as a pharmaceutical manufacturer and CDMO services provider. Operations include production of prescription drugs and hospital supplies, alongside contract services for prefilled syringes and oral solid forms. Focus is placed on biosimilars and low-molecular-weight heparin. Investments are made in research and development to support growth. A portfolio of own and licensed products is maintained across various categories.

  • Headquarters Pozuelo De Alarcon, Spain
  • Employees 2,200
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website rovi.es
  • Social LinkedIn
  • Legal Name Laboratorios Farmaceuticos Rovi, S.A.
Key Metrics
  • Annual Revenue
    $873.59 M (USD)
    -2.65
    as on Dec 31, 2025
  • Net Profit
    $165.02 M (USD)
    2.6
    as on Dec 31, 2025
  • EBITDA
    $239.14 M (USD)
    -1.55
    as on Dec 31, 2025
  • Latest Funding Round
    $92.85M (USD), Post-IPO

    Sep 2018

  • Employee Count
    2,200

Funding Insights of Rovi

  • Total Rounds 1
  • Last Round Post-IPO β€” $92.85M
  • First Round $92.85M

    (Sep 2018)

All 1 funding rounds of Rovi with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2018$92.85MPost-IPO––
–

People of Rovi

2 people are tracked at Rovi (2 in leadership); the tracked headcount is 2,200.

NameRoleGroup
Juan Encina
CEOLeadership
Javier Lopez Belmonte
Vice President & Chief Financial OfficerLeadership
Premium access

Complete people profiles for Rovi

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Rovi

Rovi is a publicly listed company on the BME with ticker symbol ROVI in Spain, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date05 Dec 2007
  • Listed onBME: ROVI
  • Listed entityLaboratorios Farmaceuticos Rovi, S.A.
  • Exchange sectorHealth technology
  • ISINES0157261019
  • Share price58.35 EUR (+1.57% on the day) · 2026-10-14
  • Market capitalisation2,905,136,067.00 EUR
  • Price to earnings16.1
  • EPS (diluted, trailing year)3.62 EUR
  • Dividend yield1.35%
  • Volume (last session)13,643

Financials of Rovi

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025743.5M EUR140.4M EUR203.5M EUR
2024763.8M EUR136.9M EUR206.7M EUR
2023829.5M EUR170.3M EUR243.8M EUR
2022817.7M EUR199.7M EUR276.6M EUR
2021648.7M EUR153.1M EUR203.1M EUR
Premium access

Detailed financial statements for Rovi

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Rovi

3 dated milestones of Rovi across 72 years, from founding to its latest funding, stage changes and deals.

  1. Founded Rovi is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $92.8M.

Web traffic of Rovi

The website of Rovi (rovi.es) receives about 17.2K visits a month and ranks #1,303,574 among all websites worldwide, #1,674 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    17.2K

    ▼ 17.7% vs previous month

  • Unique visitors
    8.7K

    per month

  • Global rank
    #1,303,574

    among all websites

  • Category rank
    #1,674

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Rovi. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
reigjofre.com
100%
5.1K#3,405,973View details
arkopharma.com
97%
220.4K#215,630View details
servier.com
93%
306.8K#150,173View details
medinfar.pt
medinfar.pt
93%
#1,731,584–
cinfa.com
76%
640.7K#105,172View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 24 similar websites and full traffic analytics for Rovi

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 24 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Rovi

Premium access

Complete news archive for Rovi

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rovi

Rovi was founded in 1946 and raised its 1st funding round 72 years after it was founded.

Rovi is headquartered in Pozuelo De Alarcon, Spain. It is registered at Pozuelo De Alarcon, Madrid, Spain.

Juan Encina is the CEO of Rovi, as recorded in our data.

Rovi has 2,200 employees.

Annual revenue of Rovi is $873.59M as on Dec 31, 2025.

Rovi was founded in 1946 as a pharmaceutical manufacturer and CDMO services provider. Operations include production of prescription drugs and hospital supplies, alongside contract services for prefilled syringes and oral solid forms. Focus is placed on biosimilars and low-molecular-weight heparin. Investments are made in research and development to support growth. A portfolio of own and licensed products is maintained across various categories.

Yes, Rovi is publicly traded on BME under the ticker symbol ROVI.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available